当前位置：
X-MOL 学术
›
Eur. Urol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Re: Overall Survival with Adjuvant Pembrolizumab in Renal-cell Carcinoma
European Urology ( IF 25.3 ) Pub Date : 2024-07-22 , DOI: 10.1016/j.eururo.2024.06.014 Zhenbang Liu 1 , Haidar AlSaffar 2 , Sachin Perera 2 , Elio Mazzone 2 , Nathan Lawrentschuk 3 , Renu Eapen 4 , Declan G Murphy 4 , Marlon L Perera 5
中文翻译：
回复：Pembrolizumab 辅助治疗肾细胞癌的总生存期
更新日期：2024-07-22
European Urology ( IF 25.3 ) Pub Date : 2024-07-22 , DOI: 10.1016/j.eururo.2024.06.014 Zhenbang Liu 1 , Haidar AlSaffar 2 , Sachin Perera 2 , Elio Mazzone 2 , Nathan Lawrentschuk 3 , Renu Eapen 4 , Declan G Murphy 4 , Marlon L Perera 5
Affiliation
中文翻译：
回复：Pembrolizumab 辅助治疗肾细胞癌的总生存期
京公网安备 11010802027423号